These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1153061)

  • 21. [Use of biperiden in delayed-release form in the treatment of Parkinson's disease and parkinsonian syndromes of various etiologies. Clinical experiments].
    Puntoni U
    Clin Ter; 1983 Oct; 107(1):37-44. PubMed ID: 6653070
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of methamidoline in the treatment of parkinson-like manifestations due to neuroleptics].
    Arnone A; Parodi A
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1126-42. PubMed ID: 5143724
    [No Abstract]   [Full Text] [Related]  

  • 23. [Amandatine hydrochloride (Symmetrel) in the treatment of parkinsonism].
    Nikolić M; Lević Z
    Srp Arh Celok Lek; 1976 Feb; 104(2):113-8. PubMed ID: 1013802
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopamine analogues for studies of parkinsonism.
    Cotzias GC; Düby S; Ginos JZ; Steck A; Papavasiliou PS
    N Engl J Med; 1970 Dec; 283(23):1289. PubMed ID: 5476485
    [No Abstract]   [Full Text] [Related]  

  • 25. [Meprotixol (N 7020). Clinical experiences in rheumatic diseases].
    Kogstad O
    Tidsskr Nor Laegeforen; 1974 Feb; 94(4):212-4. PubMed ID: 4595469
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II study of hycanthone in patients with advanced colorectal carcinoma.
    Schutt AJ; Dalton RJ; Kovach JS; Moertel CG; O'Connell MJ
    Cancer Treat Rep; 1983 Jun; 67(6):593-4. PubMed ID: 6861166
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic experiences with amantadine sulfate as a monotherapeutic drug in patients with Parkinsonism].
    Völler GW; Deze J
    Z Allgemeinmed; 1973 May; 49(14):664-70. PubMed ID: 4585272
    [No Abstract]   [Full Text] [Related]  

  • 28. [Imipramine in parkinsonism].
    Schmidt P
    Psychiatr Neurol Med Psychol (Leipz); 1973 Oct; 25(10):631-6. PubMed ID: 4777369
    [No Abstract]   [Full Text] [Related]  

  • 29. Actions of dopaminergic agonists in parkinsonism.
    McDowell FH; Sweet R
    Adv Neurol; 1975; 9():367-71. PubMed ID: 1096573
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experience with depot neuroleptics].
    Arató M; Erdós A
    Orv Hetil; 1979 Apr; 120(17):1015-21. PubMed ID: 372888
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term results of L-dopa treatment of parkinsonism].
    Barbeau A
    Union Med Can; 1975 Jan; 104(1):32-8. PubMed ID: 1111195
    [No Abstract]   [Full Text] [Related]  

  • 32. Flupenthixol (fluanxol) in the treatment of psychosomatic disorders in medicine.
    Van Coller PE
    Psychosomatics; 1971; 12(4):256-9. PubMed ID: 5172942
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of parkinsonism using L-Dopa (Brocadopa)].
    Jörg J
    Med Welt; 1975 Jan; 26(3):124-6. PubMed ID: 1110622
    [No Abstract]   [Full Text] [Related]  

  • 34. [Septicemic salmonellosis of long duration. Treatment of intercurrent schistosomiasis mansoni with hycanthone].
    Marinho RP; Neves J
    Rev Inst Med Trop Sao Paulo; 1974 Mar; 16(2):70-6. PubMed ID: 4845453
    [No Abstract]   [Full Text] [Related]  

  • 35. [Parkinsonism].
    Stoliarova LG; Kadykov AS
    Klin Med (Mosk); 1984 May; 62(5):115-20. PubMed ID: 6748569
    [No Abstract]   [Full Text] [Related]  

  • 36. [Meprotixol (N 7020). Studied in rheumatic diseases in a double blind multicenter investigation in general practice].
    Kogstad O; Apall-Olsen P; Fjerdingstad S; Garfelt R; Helgesen RO; Joheim I; Klaastad R; Rosenberg I; Selvåg J; Toreid K; Tonnessen JS
    Tidsskr Nor Laegeforen; 1974 Feb; 94(4):209-12. PubMed ID: 4595468
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopaminergic agonists in Parkinsonism.
    Claveria LE; Teychenne PF; Calne DB; Petrie A; Bassendine MF
    Adv Neurol; 1975; 9():383-92. PubMed ID: 1096576
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic effect of budipin in treating Parkinson's disease].
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):197-8. PubMed ID: 4075906
    [No Abstract]   [Full Text] [Related]  

  • 39. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
    Kissel P; Andre JM; Jacquier A
    Nouv Presse Med; 1976 Jan; 5(4):210. PubMed ID: 1264671
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experiences in the treatment of Parkinsonism using a combination of L-dopa and alpha-methyldopa-hydrazine].
    Vymazal J; Roth B; Nevsímal O
    Cesk Neurol Neurochir; 1976 Mar; 39(2):59-62. PubMed ID: 1260921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.